INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Biocon Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532523	ISIN Demat INE376G01013	Book Value 90.70	NSE Symbol BIOCON	Dividend Yield (%) 0.16	Market Cap (₹ Cr.) 38,004.99	P/E 0	EPS 0.12	Face Value 5

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	2,127.30	1,992.90	1,738.20	2,028.40	1,988.40
Sale of Products	1,712.40	1,729.40	1,494.90	1,818.80	1,811.70
Sale of Services	11.20	2.10	2.50	4.00	3.40
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	403.70	261.40	240.80	205.60	173.30
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	2,127.30	1,992.90	1,738.20	2,028.40	1,988.40
Other Income	193.00	271.40	187.20	150.20	201.70
Total Revenue	2,320.30	2,264.30	1,925.40	2,178.60	2,190.10
Changes in Inventories	-99.10	3.20	-105.80	36.70	-31.40
Cost of Material Consumed	1,033.30	978.90	912.30	760.70	858.20
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	0.50	2.10	1.70	0.90	0.90
Employee Benefits	452.30	433.80	367.70	390.20	344.80
Total Other Expenses	477.60	551.40	501.20	527.40	529.90
Manufacturing / Operating Expenses	370.70	406.30	361.50	333.00	311.60
Administrative and Selling Expenses	135.00	112.20	106.70	128.40	208.40
Other Expenses	-28.10	32.90	33.00	66.00	9.90
Finance Costs	198.80	69.60	0.40	0.40	1.20
Depreciation and Amortization	121.10	116.90	108.20	103.50	98.00
Total Expenses	2,184.50	2,155.90	1,785.70	1,819.80	1,801.60
Profit Before Exceptional Items and Tax	135.80	108.40	139.70	358.80	388.50
Exceptional Items Before Tax	14.50	2,862.80	0.00	0.00	159.70
Profit Before Extraordinary Items and Tax	150.30	2,971.20	139.70	358.80	548.20
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	150.30	2,971.20	139.70	358.80	548.20
Taxation	31.00	122.80	53.60	78.30	111.90
Current Tax	15.10	25.60	32.20	46.20	85.70
MAT Credit Entitlement	0.00	107.10	28.50	27.30	18.70
Deferred Tax	15.90	-9.90	-7.10	4.80	7.50
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	119.30	2,848.40	86.10	280.50	436.30
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	4.60
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	11.70
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	-7.10
Profit Attributable to Shareholders	119.30	2,848.40	86.10	280.50	440.90
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	119.30	2,848.40	86.10	280.50	440.90
Earning Per Share - Basic	1.00	23.87	0.72	2.36	3.72
Earning Per Share - Diluted	1.00	23.82	0.72	2.34	3.71
Operation Profit before Depreciation	455.70	294.90	248.30	462.70	487.70
Operating Profit after Depreciation	334.60	178.00	140.10	359.20	389.70
Dividend Per Share	0.50	1.50	0.50	0.00	0.00
Dividend Percentage	10.00	30.00	10.00	0.00	0.00
Equity Dividend	60.03	180.09	60.03	0.00	0.00
Weighted Average Shares - Basic	119.54	119.31	119.11	118.71	118.41
Weighted Average Shares - Diluted	119.69	119.59	119.64	119.68	118.73